| Issue | Title | |
| Vol 2013, No 1 (2013) | Bayer Heaalthcare | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2011, No 1 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 2 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 3 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 4 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 5 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 6 (2011) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 1 (2012) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 2 (2012) | Bayer Healthcare | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 3 (2012) | Bayer Healthcare | Abstract |
| Nigel Borshell, Taskin Ahmed | ||
| Vol 2012, No 1 (2012) | Big Pharma Increasingly Pursues Long-Term Deal Investment | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 1 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 2 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 3 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 4 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 5 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 6 (2011) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 1 (2012) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 2 (2012) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell | ||
| Vol 2012, No 3 (2012) | Bristol-Myers Squibb | Abstract |
| Nigel Borshell, Taskin Ahmed | ||
| Vol 2012, No 4 (2012) | Bristol-Myers Squibb | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2013, No 1 (2013) | Bristol-Myers Squibb | Abstract |
| Heather Cartwright, Taskin Ahmed | ||
| Vol 2011, No 1 (2011) | Eli Lilly | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 2 (2011) | Eli Lilly | Abstract |
| Nigel Borshell | ||
| Vol 2011, No 3 (2011) | Eli Lilly | Abstract |
| Nigel Borshell | ||
| 26 - 50 of 143 Items | << < 1 2 3 4 5 6 > >> | |